Navigation Links
Start Licensing, Inc. Further Strengthens Position in Cloning Industry With New Patents
Date:12/11/2007

New Patents Announced for Methods of Cloning Livestock From Differentiated Donor Cells

AUSTIN, Texas, Dec. 11 /PRNewswire-USNewswire/ -- Start Licensing, Inc. (Start) announced today that the U.S. Patent and Trademark Office has granted U.S. Patent Nos. 7,304,204 and 7,307,198 covering methods of cloning ungulate animals, fetuses and embryos using differentiated cells. These two patents are part of a portfolio of patents and patent applications owned by Roslin Institute that are directed to foundational somatic cell nuclear transfer (SCNT) cloning technology developed at Roslin Institute for the cloning of Dolly the sheep. This portfolio is exclusively licensed to Start for all non-human animal cloning applications.

In addition, the Patent Office has also recently issued notices of allowance for related patent applications in the portfolio, including U.S. Patent Application Nos. 09/650,194 and U.S. 09/989,126 directed to methods of cloning ungulate animals, fetuses and embryos, and of producing mammalian inner cell mass cells. The allowance of these two applications is a direct result of patent interference proceedings initiated at the Patent Office between the 09/650,194 and 09/989,126 applications and U.S. Patents 5,945,577 and 6,234,970, owned by the University of Massachusetts and exclusively licensed to Advanced Cell Technology. A patent interference is a proceeding conducted by the Patent Office when two or more parties claim the same invention in patent filings. Under U.S. law, only the party that is first to invent a new technology is entitled to a patent. The interference proceedings were decided in favor of the 09/650,194 and 09/989,126 applications and judgment was entered against the 5,945,577 and 6,234,970 patents.

Other patents in the portfolio include recently granted U.S. Patent No. 7,232,938 directed to method of cloning ungulates through fusion or microinjection of a quiescent ungulate donor cell. Metabolic changes indicative of cell quiescence include, among other things, the presence of condensed chromatin.

"These patents and allowed applications further strengthen our animal cloning patent position," said Jonathan Thatcher, Chairman of Start Licensing. "The technology covered by the Roslin patents and patent applications has been widely adopted and has increasingly important commercial applications for a wide variety of industries, including agriculture and healthcare. It has been used to clone a broad range of species including cattle, sheep, pigs, goats, horses, mice, rats, rabbits, cats and dogs."

About Start Licensing

Start is a joint venture of Geron Corporation (NASDAQ: GERN) and Exeter Life Sciences, Inc. Start manages and licenses a broad portfolio of intellectual property rights related to animal reproductive technologies, including foundational nuclear transfer cloning technology developed at the Roslin Institute for the cloning of Dolly the sheep. Start's licensees are on the cutting edge of research and product development in food production, medical applications and many other fields.

For more information, call Natalie Garrett, Start Licensing/Turner Strategies, 202-466-9633


'/>"/>
SOURCE Start Licensing, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Underage drinking starts before adolescence
2. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
3. Parents Shouldnt Forget Scoliosis Checks as School Starts
4. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
5. Motherhood(R) Maternity Joins March of Dimes to Give Babies a Healthy Start in Life
6. LeMaitre Vascular to Start Italian Sales Force
7. Blunt: Time to Stop the Politics on SCHIP, and Start the Negotiations
8. Congress Starts Hearings on FDAs Control of Tobacco
9. Jane Fonda and Bright Starts(TM) Celebrates Pink Power Moms at Susan G. Komen for the Cure Pink Tie Ball
10. Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
11. Penn wins $5M to start center for ethical, legal and social implications research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... ... The Golseth Agency, a Texas based insurance management and financial planning assistance ... campaign organized to provide support to Christina Upchurch and her two children after the ... children returned from out of town to find her husband passed away and their ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving ... Diane is from Southwest Nebraska where she was raised on a farm. ... The story is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... of high-quality anti-aging skincare solutions, recently announced the launch of two ... are an affordable, yet effective alternative to expensive plastic surgery or in-patient cosmetic ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Case #10-5411 Veterans Administration”: a ... “Case #10-5411 Veterans Administration” is the creation of published author, Carol Mulhern, ... 1990, Carol Mulhem started work at the Coatesville VAMC as a file clerk ...
Breaking Medicine News(10 mins):
(Date:8/2/2017)... and BENTON, Ky. , Aug. 2, 2017   Marshall County Hospital ... environmental services (ES) team to proactively reduce the risk of hospital-acquired infections (HAIs). The new ... robot that uses UVC light energy to kill deadly pathogens such as C. diff ... Tru-D SmartUVC ... Tru-D in action in a ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
(Date:7/31/2017)... Surgical, developer of ground breaking surgical navigation technologies, announced today ... support its strategic sales plan in Maryland ... Surgical has entered into an exclusive sales representative agreement with ... those markets. ... Spartan Medical Purchases 7D Surgical Technology ...
Breaking Medicine Technology: